You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 19, 2025

Drug Price Trends for AUBRA EQ-28 TABLET


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for AUBRA EQ-28 TABLET

Average Pharmacy Cost for AUBRA EQ-28 TABLET

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
AUBRA EQ-28 TABLET 50102-0220-21 0.14071 EACH 2024-12-18
AUBRA EQ-28 TABLET 50102-0220-23 0.14071 EACH 2024-12-18
AUBRA EQ-28 TABLET 50102-0220-21 0.12769 EACH 2024-11-20
AUBRA EQ-28 TABLET 50102-0220-23 0.12769 EACH 2024-11-20
AUBRA EQ-28 TABLET 50102-0220-21 0.15509 EACH 2024-10-23
AUBRA EQ-28 TABLET 50102-0220-23 0.15509 EACH 2024-10-23
AUBRA EQ-28 TABLET 50102-0220-21 0.19122 EACH 2024-09-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Aubra EQ-28 Tablet

Introduction to Aubra EQ

Aubra EQ, a combination oral contraceptive containing ethinyl estradiol and levonorgestrel, is widely used for birth control. Understanding its market dynamics and price projections is crucial for both consumers and industry stakeholders.

Current Pricing and Availability

As of the current date, the cost of Aubra EQ (20 mcg-100 mcg) oral tablets varies depending on the pharmacy and any available discounts. Here are some key pricing points:

  • Cash Price: The cost for a supply of 84 tablets is approximately $37.03, using a discount card accepted at most U.S. pharmacies[1].
  • Generic Version: A generic version of Aubra EQ is available, which can be significantly cheaper, with prices starting from around $37 for 84 tablets[1].

Market Trends in the Pharmaceutical Industry

Generic Drug Market

The generic drug industry, which includes Aubra EQ, is expected to experience mid-single-digit percent annual price erosion in 2024. However, this is anticipated to be offset by a return to modest revenue growth, an improvement from recent trends[3].

Biosimilars and Competition

While biosimilars are expected to see substantial revenue growth, intense competition may limit profitability. This competitive landscape could indirectly affect the pricing strategies of generic drugs like Aubra EQ[3].

Patient Assistance and Copay Programs

For individuals who find the cost of Aubra EQ prohibitive, several patient assistance programs are available:

  • Patient Access Network Foundation (PAN): This program offers cost-free or discounted medicines to individuals with low income or those who are uninsured/under-insured. Eligibility criteria include residing in the U.S., having health insurance that covers the medication, and meeting specific income thresholds[1].

Impact of Regulatory and Legal Factors

FDA Inspections and Litigation

The generic drug industry, including manufacturers of Aubra EQ, faces potential risks such as increased FDA inspections of foreign manufacturing facilities and ongoing price-fixing litigation. These factors could influence production costs and subsequently affect pricing[3].

Clinical and Pharmacological Aspects

Understanding the clinical and pharmacological aspects of Aubra EQ can provide insights into its market demand and stability.

  • Mode of Action: Aubra EQ works by suppressing gonadotropins, inhibiting ovulation, and altering cervical mucus and endometrium to prevent pregnancy[5].
  • Pharmacokinetics: The drug's pharmacokinetic parameters show consistent serum concentrations across different races, but there is limited data on its metabolism in patients with hepatic or renal insufficiency[5].

Consumer and Market Demand

Efficacy and Reliability

Aubra EQ is highly effective when used correctly, with low accidental pregnancy rates compared to other contraceptive methods. This efficacy contributes to its consistent market demand[5].

Brand and Generic Competition

Aubra EQ competes with other brands and generic versions of ethinyl estradiol and levonorgestrel combinations, such as Vienva, Aviane, Lutera, and Alesse. The availability of these alternatives can influence pricing and market share[1].

Price Projections

Given the current market trends:

  • Short-Term: Prices are expected to remain relatively stable, with potential minor reductions due to generic competition and patient assistance programs.
  • Long-Term: The mid-single-digit percent annual price erosion in the generic drug industry may lead to gradual price decreases over the next few years. However, this will be balanced by modest revenue growth, ensuring the drug remains a viable option in the market[3].

Key Takeaways

  • Current Pricing: Around $37.03 for 84 tablets, with discounts available.
  • Market Trends: Expected price erosion balanced by modest revenue growth.
  • Patient Assistance: Programs like PAN offer cost-free or discounted medicines.
  • Regulatory Factors: Potential risks from FDA inspections and litigation.
  • Clinical Efficacy: High effectiveness in preventing pregnancy.
  • Market Demand: Consistent demand due to efficacy and reliability.

FAQs

What is Aubra EQ used for?

Aubra EQ is used for the prevention of pregnancy in women who choose oral contraceptives as their method of contraception[5].

How much does Aubra EQ cost?

The cost of Aubra EQ is around $37.03 for a supply of 84 tablets, depending on the pharmacy and any available discounts[1].

Are there any patient assistance programs for Aubra EQ?

Yes, programs like the Patient Access Network Foundation (PAN) offer cost-free or discounted medicines to eligible individuals[1].

What are the potential risks associated with using Aubra EQ?

Cigarette smoking increases the risk of serious cardiovascular side effects, and there are precautions for women over 35 years old who smoke. Additionally, there are potential drug-drug interactions and risks associated with hepatic or renal insufficiency[5].

Can I get a generic version of Aubra EQ?

Yes, a generic version of Aubra EQ is available, which can be significantly cheaper than the brand name version[1].

Sources

  1. Drugs.com: Aubra EQ Prices, Coupons, Copay Cards & Patient Assistance.
  2. WellRx: Aubra Eq: Price, Uses, & Interactions.
  3. S&P Global: Pharmaceutical Industry 2024 Credit Outlook Is Stable As Revenue Growth Mitigates Pressures.
  4. Aetna Health Exchange Plan: 2025 Plan Details.
  5. Drugs.com: Aubra EQ: Package Insert / Prescribing Information.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.